Last reviewed · How we verify

Akineton — Competitive Intelligence Brief

Akineton (BIPERIDEN) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anticholinergic. Area: Neuroscience.

marketed Anticholinergic Muscarinic acetylcholine receptor M1 Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Akineton (BIPERIDEN) — AbbVie.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Akineton TARGET BIPERIDEN AbbVie marketed Anticholinergic Muscarinic acetylcholine receptor M1 1959-01-01
Northera DROXIDOPA Lundbeck Na Ltd marketed Catecholamine Muscarinic acetylcholine receptor M1 2014-01-01
Vesicare SOLIFENACIN Astellas Pharma marketed Cholinergic Muscarinic Antagonist Muscarinic acetylcholine receptor M1 2004-01-01
Evoxac CEVIMELINE Cosette marketed Cholinergic Receptor Agonist Muscarinic acetylcholine receptor M1 2000-01-01
Detrol TOLTERODINE Upjohn marketed Cholinergic Muscarinic Antagonist Muscarinic acetylcholine receptor M1 1998-01-01
Provocholine METHACHOLINE Methapharm marketed Cholinergic Receptor Agonist Muscarinic acetylcholine receptor M1 1986-01-01
Atrovent IPRATROPIUM marketed Anticholinergic Muscarinic acetylcholine receptor M1 1986-01-01

Recent regulatory actions (last 90 days)

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anticholinergic class)

  1. · 4 drugs in this class
  2. Pearl Therapeutics, Inc. · 3 drugs in this class
  3. Shionogi · 2 drugs in this class
  4. Ain Shams University · 1 drug in this class
  5. Astellas Pharma Inc · 1 drug in this class
  6. Boehringer Ingelheim · 1 drug in this class
  7. Covis · 1 drug in this class
  8. Forest Labs Inc · 1 drug in this class
  9. Fougera Pharms · 1 drug in this class
  10. Glaxo Grp England · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Akineton — Competitive Intelligence Brief. https://druglandscape.com/ci/biperiden. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: